BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 171110)

  • 1. Complement-induced mixed aggregation of T and B lymphocytes and myeloid cells and the effect of adjuvant.
    Arnaiz-Villena A; Roitt IM
    Clin Exp Immunol; 1975 Jul; 21(1):115-20. PubMed ID: 171110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of cyclophosphamide on antibody formation in the mouse.
    Willers JM; Sluis E
    Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant-induced selective recruitment of specifically reactive lymphocytes: a probable mechanism of adjuvant action.
    Emeson EE
    J Immunol; 1980 May; 124(5):2222-30. PubMed ID: 6245138
    [No Abstract]   [Full Text] [Related]  

  • 4. Macrophage requirements of CR- and CR+ B lymphocytes for antibody production in vitro.
    Hoffmann MK; Hämmerling U; Simon M; Oettgen HF
    J Immunol; 1976 May; 116(5):1447-51. PubMed ID: 1083874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor synergistically acts with IFN-gamma to regulate Ly-6A/E expression in T lymphocytes, thymocytes and bone marrow cells.
    Malek TR; Danis KM; Codias EK
    J Immunol; 1989 Mar; 142(6):1929-36. PubMed ID: 2493502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease.
    Dorshkind K; Keller GM; Phillips RA; Miller RG; Bosma GC; O'Toole M; Bosma MJ
    J Immunol; 1984 Apr; 132(4):1804-8. PubMed ID: 6607948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse bone marrow lymphocytes and their differentiation.
    Ryser JE; Vassalli P
    J Immunol; 1974 Sep; 113(3):719-28. PubMed ID: 4213258
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular analysis of immunosuppression to synthetic polypeptide immunogens induced by a murine leukemia virus.
    Shearer GM; Mozes E; Haran-Ghera N; Bentwich Z
    J Immunol; 1973 Mar; 110(3):736-41. PubMed ID: 4347477
    [No Abstract]   [Full Text] [Related]  

  • 11. Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen.
    Desombere I; Willems A; Gijbels Y; Leroux-Roels G
    J Virol; 2006 Apr; 80(7):3506-14. PubMed ID: 16537618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell and interferon-gamma involvement in the adjuvant action of a detoxified endotoxin.
    Tomai MA; Johnson AG
    J Biol Response Mod; 1989 Dec; 8(6):625-43. PubMed ID: 2513379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro effects of Bordetella pertussis lymphocytosis-promoting factor on murine lymphocytes. V. Modulation of T cell proliferation by helper and suppressor lymphocytes.
    Ho MK; Kong AS; Morse SI
    J Immunol; 1980 Jan; 124(1):362-9. PubMed ID: 6243149
    [No Abstract]   [Full Text] [Related]  

  • 14. B lymphocytes and macrophages release cell membrane deposited C3-fragments on exosomes with T cell response-enhancing capacity.
    Papp K; Végh P; Prechl J; Kerekes K; Kovács J; Csikós G; Bajtay Z; Erdei A
    Mol Immunol; 2008 Apr; 45(8):2343-51. PubMed ID: 18192019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of cyclophosphamide on the delayed hypersensitivity of the mouse.
    Kerckhaert JA; Van den Berg GJ; Willers JM
    Ann Immunol (Paris); 1974; 125(3):415-26. PubMed ID: 4606666
    [No Abstract]   [Full Text] [Related]  

  • 16. IL-2 and IL-4 can co-modulate the generation of cytotoxic T cells through CD8- CD4- splenic lymphocytes.
    Good MF; Powell LW; Halliday JW
    Immunology; 1989 Jun; 67(2):225-30. PubMed ID: 2568977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential requirement for B-memory and T-memory cells in adoptive antibody formation in mouse bone marrow.
    Koch G; Benner R
    Immunology; 1982 Apr; 45(4):697-704. PubMed ID: 6978285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A myeloid cell population induced by Freund adjuvant suppresses T-cell-mediated antitumor immunity.
    Wang Z; Jiang J; Li Z; Zhang J; Wang H; Qin Z
    J Immunother; 2010; 33(2):167-77. PubMed ID: 20145547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression on mouse lymphoid cells of Th-B, an antigen common to mouse B cells and thymus cells.
    Yutoku M; Grossberg AL; Pressman D
    J Immunol; 1975 Jul; 115(1):69-74. PubMed ID: 1097506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The xenogeneic effect. II. Requirement for unactivated murine T cells during restoration of immune responsiveness with xenogeneic reconstitution factor.
    Farrar JJ; Fuller-Bonar J
    J Immunol; 1976 Jul; 117(1):274-82. PubMed ID: 778265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.